Life Spine has received clearance from the US Food and Drug Administration (FDA) to market the GHOST 3D-printed titanium spacer system, which includes new implants for anterior lumbar interbody fusion (ALIF), posterior / transforaminal lumbar interbody fusion (PLIF/TLIF) and lateral procedures.
GHOST spacers integrate porous surfaces designed to promote bony on-growth while maintaining a robust external lattice geometry, say Life Spine. GHOST is available in a wide range of footprints and lordotic offerings to accommodate varying patient anatomies and pathologies.
The system is supplemented by Life Spine’s wide variety of posterior fixation including the AVATAR percutaneous screw system, NAUTILUS spinal fixation system, CENTERLINE midline screw system and ARx spinal fixation system.
Mariusz Knap, senior vice president of marketing at Life Spine, said: “We are excited about the expansion of our interbody portfolio to include 3D-printed implants. Our robust offering is one of the broadest in the industry and includes solutions for nearly every procedure and surgeon preference.
“With the PEEK, titanium, and expandable interbody product lines, the addition of 3D-printed titanium interbodies allows Life Spine to offer physicians alternative solutions to customise their patient’s treatment.”